[3P-867] FOXM1-CD44 signaling mediated the Regorafenib resistance ability in　human liver cancer cells.

^○YaHan Yang^5,2,1,3, Kenly Wuputra^2,1,3, PiJung Hsiao⁴, Kazunari K. Yokoyama^2,3,1, KungKai Kuo^5,6 (1.Regen. Med. and Cell Therapy Res. Cen., KMU, 2.Grad. Inst. of Med., KMU, 3.Cell Therapy and Res. Cen., KMU, 4.Dept. of Int. Med., Div. of Endo. and Meta., EDA Hosp., College of Med., ISU, 5.Div. of GDS, Dept of Surg., KMU, 6.Dept. of Surg, Sch. of Med., Coll. of Med., KMU)